Executive Editor
- Christopher Foote, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Clinical Pathology 2013, 13:14CNS tumors in China
The number of central nerve system tumors treated at a single center in China has increased substantially over the last 60 years, with lymphoma and hematopoietic neoplasm cases particularly high
-
BMC Clinical Pathology 2013, 13:13Improved evaluation of HER2 status
Automated FISH evaluation of HER2 gene status has a strong concordance with the traditional manual method, providing a quicker and more efficient method to assess the suitability of trastuzumab in treating breast cancer patients
-
BMC Clinical Pathology 2013, 13:3Markers in primary and metastatic renal tumors
Expression levels of most common drug targets are the same in both primary and metastatic renal carcinoma tumors, meaning that biomarker tests could be used on either tumor type
- View more articles
Scope
BMC Clinical Pathology is an open access, peer-reviewed journal that considers articles on all aspects of histopathology, haematology, clinical biochemistry, and medical microbiology (including virology, parasitology, and infection control).
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
BMC series blog
Email updates
Receive periodic news and updates relating to BioMed Central straight to your inbox.
